当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析 - 现金流量表

济川药业

(600566)

  

流通市值:254.26亿  总市值:255.12亿
流通股本:9.19亿   总股本:9.22亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,428,914,069.916,639,124,884.525,113,363,265.263,854,281,141.73
  收到其他与经营活动有关的现金67,834,825.8117,544,192.93165,223,549.12135,361,470.74
  经营活动现金流入小计2,496,748,895.716,756,669,077.455,278,586,814.383,989,642,612.47
  购买商品、接受劳务支付的现金167,953,607.591,000,015,082.731,042,326,910.81561,222,142.9
  支付给职工以及为职工支付的现金275,877,645.77801,103,602.03635,208,241.16463,971,131.07
  支付的各项税费338,305,925.061,086,765,833.21765,960,005.08551,348,816.71
  支付其他与经营活动有关的现金834,272,018.572,670,490,315.582,131,580,287.931,440,626,170.46
  经营活动现金流出小计1,616,409,196.995,558,374,833.554,575,075,444.983,017,168,261.14
  经营活动产生的现金流量净额880,339,698.721,198,294,243.9703,511,369.4972,474,351.33
二、投资活动产生的现金流量:
  收回投资收到的现金1,454,910,021.665,522,548,336.144,301,455,497.243,134,707,317.39
  取得投资收益收到的现金25,856,947.77190,636,990.41157,179,525.62131,964,543.77
  处置固定资产、无形资产和其他长期资产收回的现金净额600619,084.24129,452.08110,572.33
  投资活动现金流入小计1,480,767,569.435,713,804,410.794,458,764,474.943,266,782,433.49
  购建固定资产、无形资产和其他长期资产支付的现金193,682,460.0895,858,707.0471,945,552.1840,820,725.86
  投资支付的现金3,838,000,0006,594,200,0004,949,584,600.054,202,000,000
  投资活动现金流出小计4,031,682,460.086,690,058,707.045,021,530,152.234,242,820,725.86
  投资活动产生的现金流量净额-2,550,914,890.65-976,254,296.25-562,765,677.29-976,038,292.37
三、筹资活动产生的现金流量:
  吸收投资收到的现金6,595,32020,240,9962,500,0002,500,000
  取得借款收到的现金826,227,645.061,435,566,424.31761,158,197.31446,605,850.68
  筹资活动现金流入小计832,822,965.061,455,807,420.31763,658,197.31449,105,850.68
  偿还债务支付的现金640,100,000945,342,527.98495,019,590.12425,933,702.11
  分配股利、利润或偿付利息支付的现金7,311,258.61,928,582,313.441,917,334,555.031,914,503,767.51
  支付其他与筹资活动有关的现金25,284,758.3234,151,714.4831,514,184.4828,050,684.48
  筹资活动现金流出小计672,696,016.922,908,076,555.92,443,868,329.632,368,488,154.1
  筹资活动产生的现金流量净额160,126,948.14-1,452,269,135.59-1,680,210,132.32-1,919,382,303.42
四、汇率变动对现金及现金等价物的影响-10,367.13-9,939.83-103.35
五、现金及现金等价物净增加额-1,510,458,610.92-1,230,239,127.77-1,539,464,440.21-1,922,946,141.11
  加:期初现金及现金等价物余额5,439,123,615.946,669,362,743.716,669,362,743.716,669,362,743.71
  期末现金及现金等价物余额3,928,665,005.025,439,123,615.945,129,898,303.54,746,416,602.6
补充资料:
  净利润-1,778,264,104.2-725,285,908.9
  资产减值准备-474,140.79-1,140,852.47
  固定资产和投资性房地产折旧-273,734,332.62-139,719,766.85
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-273,734,332.62-139,719,766.85
  无形资产摊销-35,594,277.74-17,281,734.47
  长期待摊费用摊销-1,213,527.11-200,789.76
  处置固定资产、无形资产和其他长期资产的损失--173,234.04--68,411.54
  固定资产报废损失-445,303.46-371,876.24
  公允价值变动损失--41,312,956.01-32,509,512.31
  财务费用-11,458,926.34-7,057,473.19
  投资损失--189,887,071.97--131,621,780.6
  递延所得税--2,851,991.79-11,413,732.06
  其中:递延所得税资产减少--7,609,057.5-7,402,082.47
    递延所得税负债增加-4,757,065.71-4,011,649.59
  存货的减少-258,950,503.83-229,396,727.65
  经营性应收项目的减少--381,958,499.16-266,960,351.91
  经营性应付项目的增加--555,789,749.81--308,663,774.61
  其他-3,957,609.9-1,779,663.44
  现金的期末余额-5,439,123,615.94-4,746,416,602.6
  减:现金的期初余额-6,669,362,743.71-6,669,362,743.71
  现金及现金等价物的净增加额--1,230,239,127.77--1,922,946,141.11
公告日期2026-04-242026-04-242025-10-282025-08-23
审计意见(境内)标准无保留意见
TOP↑